Article thumbnail

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis

By Anita Gasiorowska, Renata Talar-Wojnarowska, Leszek Czupryniak, Beata Smolarz, Hanna Romanowicz-Makowska, Andrzej Kulig and Ewa Malecka-Panas
Topics: Original Article
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:3041903
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1999). A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis.
  2. (2004). Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
  3. (2006). Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis. J Pediatr Gastroenterol Hepatol.
  4. (2001). Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology.
  5. Chronic pancreatitis.
  6. Cirrhosis and chronic pancreatitis in alcoholics.
  7. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis.
  8. Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis.
  9. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis.
  10. Genetic mutations in a Spanish population with chronic pancreatitis.
  11. (1997). GorryMC,GabbaizedehD,FureyW,GatesLK,etal.Mutationsin the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis.
  12. (1996). Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet.
  13. Kalthoff L,Clain JE, Bakken LJ,DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis.
  14. (2003). Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States. Dig Dis Sci.
  15. Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci.
  16. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis.
  17. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis.
  18. Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis.
  19. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
  20. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
  21. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated withchronic pancreatitis.
  22. Mutations in the serine protease inhibitor Kazal type 1 (SPINK1) gene in Japanese patients with pancreatitis.
  23. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
  24. Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis.
  25. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis.
  26. Mutations of the cationic trypsinogen gene in patients with hereditary pancreatitis.
  27. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.
  28. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.
  29. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.
  30. Pancreatic secretory trypsin inhibitor (SPINK1) gene mutations in patients with acute pancreatitis.
  31. (1999). Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis?
  32. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.
  33. Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis.
  34. (2011). The course of genetically determined chronic pancreatitis.
  35. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease.
  36. (2011). The natural history of hereditary pancreatitis: a national series.
  37. the pancreatic secretory trypsin inhibitor in patients with pancreatitis.
  38. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
  39. Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis.